Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures

Seizure

Volumn 21, Issue 5, 2012, Pages 344-352

  Jones, Nicholas A ^a   Glyn, Sarah E ^a   Akiyama, Satoshi ^a,b   Hill, Thomas D M ^a   Hill, Andrew J ^a   Weston, Samantha E ^a   Burnett, Matthew D A ^a   Yamasaki, Yuki ^a,b   Stephens, Gary J ^a   Whalley, Benjamin J ^a   Williams, Claire M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Cannabidiol; Epilepsy; Motor function; Partial seizure; Temporal lobe seizure

Indexed keywords

CANNABIDIOL; CANNABIS; PENICILLIN G; PENTETRAZOLE; PILOCARPINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; FOCAL EPILEPSY; GRAND MAL SEIZURE; LETHALITY; MALE; MORTALITY; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; TEMPORAL LOBE EPILEPSY; TONIC CLONIC SEIZURE; VIDEORECORDING;

ANIMALS; ANTICONVULSANTS; CANNABIDIOL; DISEASE MODELS, ANIMAL; MALE; RATS; RATS, INBRED WKY; SEIZURES; TEMPORAL LOBE; TREATMENT OUTCOME;

EID: 84860685529     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2012.03.001     Document Type: Article

References (60)

1. H.L. Li An archaeological and historical account of cannabis in China Economic Botany 28 1974 437 448
2. J.C. Brust, S.K. Ng, A.W. Hauser, and M. Susser Marijuana use and the risk of new onset seizures Transactions of the American Clinical and Climatological Association 103 1992 176 181
3. D.W. Gross, J. Hamm, N.L. Ashworth, and D. Quigley Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center Neurology 62 11 2004 2095 2097 (Pubitemid 38738229)
4. M. Schnelle, F. Grotenhermen, M. Reif, and R.W. Gorter Results of a standardized survey on the medical use of cannabis products in the German-speaking area Forschende Komplementarmedizin 6 Suppl. 3 1999 28 36
5. D. Wingerchuk Cannabis for medical purposes: cultivating science, weeding out the fiction Lancet 364 2004 315 316 (Pubitemid 38969997)
6. Y. Gaoni, and R. Mechoulam Isolation, structure, and partial synthesis of an active constituent of hashish1 Journal of the American Chemical Society 86 8 1964 1646 1647
7. R.G. Pertwee The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta 9-tetrahydrocannabinol, cannabidiol and Delta 9-tetrahydrocannabivarin British Journal of Pharmacology 153 2008 199 215
8. R. Mechoulam, and Y. Shvo Hashish - I. The structure of cannabidiol Tetrahedron 19 12 1963 2073 2078
9. S. Bhattacharyya, P. Fusar-Poli, S. Borgwardt, R. Martin-Santos, C. Nosarti, and C. O'Carroll Modulation of mediotemporal and ventrostriatal function in humans by {Delta} 9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis Archives of General Psychiatry 66 4 2009 442 451
10. P. Consroe, M.A.C. Benedito, J.R. Leite, E.A. Carlini, and R. Mechoulam Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice European Journal of Pharmacology 83 3-4 1982 293 298 (Pubitemid 12001173)
11. J.M. Cunha, E.A. Carlini, A.E. Pereira, O.L. Ramos, C. Pimentel, and R. Gagliardi Chronic administration of cannabidiol to healthy volunteers and epileptic patients Pharmacology 21 3 1980 175 185 (Pubitemid 10039764)
12. E.A. Carlini, J.R. Leite, M. Tannhauser, and A.C. Berardi Letter: cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents The Journal of Pharmacy and Pharmacology 25 8 1973 664 665
13. I. Izquierdo, O.A. Orsingher, and A.C. Berardi Effect of cannabidiol and of other Cannabis sativa compounds on hippocampal seizure discharges Psychopharmacology 28 1 1973 95 102
14. R. Karler, W. Cely, and S.A. Turkanis The anticonvulsant activity of cannabidiol and cannabinol Life Sciences 13 11 1973 1527 1531
15. P. Consroe, and A. Wolkin Cannabidiol-antiepileptic drug comparisons and interactions in experimentally induced seizures in rats Journal of Pharmacology and Experimental Therapeutics 201 1 1977 26 32 (Pubitemid 8085993)
16. V. Di Marzo Targeting the endocannabinoid system: to enhance or reduce? Nature Reviews: Drug Discovery 7 5 2008 438 455 (Pubitemid 351649182)
17. A.C. Howlett, C.S. Breivogel, S.R. Childers, S.A. Deadwyler, R.E. Hampson, and L.J. Porrino Cannabinoid physiology and pharmacology: 30 years of progress Neuropharmacology 47 2004 345 358 (Pubitemid 39298276)
18. M. Shen, and S.A. Thayer 9-Tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture Molecular Pharmacology 55 1 1999 8 13 (Pubitemid 29042516)
19. M.J. Wallace, J.L. Wiley, B.R. Martin, and R.J. DeLorenzo Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects European Journal of Pharmacology 428 1 2001 51 57 (Pubitemid 32971757)
20. T. Bisogno, L. Hanuš, L. De Petrocellis, S. Tchilibon, D.E. Ponde, and I. Brandi Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide British Journal of Pharmacology 134 4 2001 845 852 (Pubitemid 33016156)
21. M.H. Rhee, Z. Vogel, J. Barg, M. Bayewitch, R. Levy, and L. Hanus Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase Journal of Medicinal Chemistry 40 20 1997 3228 3233 (Pubitemid 27413747)
22. N.A. Jones, A.J. Hill, I. Smith, S.A. Bevan, C.M. Williams, and B.J. Whalley Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo Journal of Pharmacology and Experimental Therapeutics 332 2 2010 569 577
23. E. Ryberg, N. Larsson, S. Sjögren, S. Hjorth, and N. Hermansson The orphan receptor GPR55 is a novel cannabinoid receptor British Journal of Pharmacology 152 7 2007 1092 1101 (Pubitemid 350166046)
24. A.J. Hill, C.M. Williams, B.J. Whalley, and G.J. Stephens Phytocannabinoids as novel therapeutic agents in CNS disorders Pharmacology & Therapeutics 133 1 2012 79 97
25. F. Bartolomei, M. Khalil, F. Wendling, A. Sontheimer, J. Régis, and J.P. Ranjeva Entorhinal cortex involvement in human mesial temporal lobe epilepsy: an electrophysiologic and volumetric study Epilepsia 46 5 2005 677 687 (Pubitemid 40628663)
26. R. Dingledine, and L. Gjerstad Reduced inhibition during epileptiform activity in the in vitro hippocampal slice The Journal of Physiology 305 1 1980 297 313 (Pubitemid 10048162)
27. R.K. Wong, and D.A. Prince Dendritic mechanisms underlying penicillin-induced epileptiform activity Science 204 4398 1979 1228 1231 (Pubitemid 9209455)
28. M. Bostanci, and F. Bagirici Anticonvulsive effects of quinine on penicillin-induced epileptiform activity: an in vivo study Seizure 16 2 2007 166 172 (Pubitemid 46211177)
29. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1982 Academic Press Sydney
30. J.A. Farrimond, A.J. Hill, N.A. Jones, G.J. Stephens, B.J. Whalley, and C.M. Williams A cost-effective high-throughput digital system for observation and acquisition of animal behavioral data Behavior Research Methods 41 2 2009 446 451
31. E.A. Cavalheiro, M.G. Naffah-Mazzacoratti, L.E. Mello, and J.P. Leite The pilocarpine model of seizures A. Pitkänen, P.A. Schwartzkroin, S.L. Moshe, Models of seizures and epilepsy 2006 Elsevier Academic Press London 433 448
32. S.H. Baytan, M. Alkanat, M. Okuyan, M. Ekinci, E. Gedikli, and M. Ozeren Simvastatin impairs spatial memory in rats at a specific dose level The Tohoku Journal of Experimental Medicine 214 4 2008 341 349 (Pubitemid 351761052)
33. K.M. Crofton, S. Padilla, H.A. Tilson, D.C. Anthony, J.H. Raymer, and R.C. MacPhail The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects Toxicology and Applied Pharmacology 139 1 1996 163 176 (Pubitemid 26247074)
34. M.E. Nevins, S.A. Nash, and P.M. Beardsley Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice Psychopharmacology (Berl) 110 1-2 1993 92 96 (Pubitemid 23029432)
35. S.E. Hamilton, M.D. Loose, M. Qi, A.I. Levey, B. Hille, and G.S. McKnight Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice Proceedings of the National Academy of Sciences of the United States of America 94 24 1997 13311 13316 (Pubitemid 27518518)
36. D.B. Clifford, J.W. Olney, A. Maniotis, R.C. Collins, and C.F. Zorumski The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures Neuroscience 23 3 1987 953 968 (Pubitemid 18014408)
37. M. Esclapez, J.C. Hirsch, Y. Ben-Ari, and C. Bernard Newly formed excitatory pathways provide a substrate for hyperexcitability in experimental temporal lobe epilepsy Journal of Comparative Neurology 408 4 1999 449 460 (Pubitemid 29211174)
38. K. Goffin, J. Nissinen, K. Van Laere, and A. Pitkänen Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat Experimental Neurology 205 2 2007 501 505 (Pubitemid 46755770)
39. J.P. Leite, Z.A. Bortolotto, and E.A. Cavalheiro Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy Neuroscience & Biobehavioral Reviews 14 4 1991 511 517
40. A.K. Sharma, R.Y. Reams, W.H. Jordan, M.A. Miller, H.L. Thacker, and P.W. Snyder Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions Toxicologic Pathology 35 7 2007 984 999
41. M.D. Bhaskaran, and B.N. Smith Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy Experimental Neurology 2010 10.1016/j.expneurol.2010.01.021
42. K.J. Ressler, and C.B. Nemeroff Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders Depression and Anxiety 12 Suppl. 1 2000 2 19
43. H. Hecimovic, J. Salpekar, A.M. Kanner, and J.J. Barry Suicidality and epilepsy: a neuropsychobiological perspective Epilepsy and Behavior 22 2011 77 84
44. G.B. Richerson, and G.F. Buchanan The serotonin axis: shared mechanisms in seizures, depression and SUDEP Epilepsia 52 Suppl. 1 2011 28 38
45. J. Edeh, and B. Toone Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice The British Journal of Psychiatry 151 1 1987 95 101 (Pubitemid 17117633)
46. W.H. Theodore Does serotonin play a role in epilepsy? Epilepsy Currents 3 5 2003 173 177
47. E.B. Russo, A. Burnett, B. Hall, and K.K. Parker Agonistic properties of cannabidiol at 5-HT1a receptors Neurochemical Research 30 8 2005 1037 1043 (Pubitemid 41570039)
48. A.T. El-Alfy, K. Ivey, K. Robinson, S. Ahmed, M. Radwan, and D. Slade Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. Pharmacology, Biochemistry, and Behavior 95 4 2010 434 442
49. T.V. Zanelati, C. Biojone, F.A. Moreira, F.S. Guimaraes, and S.R. Joca Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors British Journal of Pharmacology 159 1 2010 122 128
50. E. Russo, R. Citraro, F. Scicchitano, A. Urzino, R. Marra, and V. Rispoli Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity Behavioural Brain Research 225 1 2011 373 376
51. J. Martin British national formulary 59th ed. 2010 Pharmaceutical Press London
52. F.H. Yu, and W.A. Catterall Overview of the voltage-gated sodium channel family Genome Biology 4 3 2003 207
53. 2+ levels Journal of Neuroscience 29 7 2009 2053 2063
54. R. Andrade, and R.A. Nicoll Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro The Journal of Physiology 394 1 1987 99 124 (Pubitemid 18005126)
55. M. Segal The action of serotonin in the rat hippocampal slice preparation The Journal of Physiology 303 1 1980 423 439 (Pubitemid 10078598)
56. J.S. Sprouse, and G.K. Aghajanian Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists Synapse 1 1 1987 3 9 (Pubitemid 17114243)
57. 18F] MPPF-PET study Brain 127 4 2004 900 1013
58. D. Boison Adenosine kinase, epilepsy and stroke: mechanisms and therapies Trends in Pharmacological Sciences 27 12 2006 652 658 (Pubitemid 44738092)
59. E.J. Carrier, J.A. Auchampach, and C.J. Hillard Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression Proceedings of the National Academy of Sciences of the United States of America 103 20 2006 7895 7900
60. A.A. Izzo, F. Borrelli, R. Capasso, V. Di Marzo, and R. Mechoulam Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb Trends in Pharmacological Sciences 30 10 2009 515 527